Hook
153 private funds. One target. Changxin Memory Technologies (CXMT). On July 18, 2024, High-Flyer, Liang Wenfeng's quant behemoth, deployed 153 distinct products to subscribe to CXMT's Shanghai IPO. Price tag: 8.78 RMB per share. Total shares: 6.688 billion. Implied valuation: 2 to 5 trillion RMB. That's $280 to $700 billion. For context, Micron—a global DRAM giant—sits at roughly $100 billion. This is not a typical IPO subscription. This is a statement.
Context
CXMT is the only DRAM manufacturer inside China's borders. It produces DDR5 on a 17nm node—roughly equivalent to Samsung's 1z generation. The gap is real: global leaders are already shipping 1β (12nm) and HBM3E. CXMT has no HBM product. None. Yet the market values it above Micron. Why? Because of the decoupling narrative.
China's semiconductor self-sufficiency drive is not a slogan—it's a liquidity channel. The state-backed "Big Fund III" just raised 344 billion RMB, with memory as a core focus. CXMT is the primary beneficiary. Its technology is not world-leading, but it is domestic. For policy makers, that's enough.
High-Flyer is no stranger to hardware. As the largest quantitative hedge fund in China, its trading and AI models depend on massive GPU clusters. Those clusters require high-bandwidth memory (HBM). HBM is currently exclusive to Samsung, SK Hynix, and Micron. With US export controls tightening, Chinese AI firms face a supply crisis. High-Flyer is betting that CXMT can eventually fill that gap.
Core Insight
Let's break this down through a macro liquidity lens. Every IPO is a transfer of capital from the secondary market to the issuer. But this one is different. High-Flyer used 153 products—likely a mechanism to bypass single-fund subscription limits and to signal concentrated demand. The sheer number tells me this is not a passive allocation. It is active, strategic, and potentially coordinated.
The technicals confirm the risk. CXMT's 17nm node yields roughly 60-70% versus the industry standard of 85-90%. That 20-point gap translates into 30-40% higher cost per die. In a commodity market like DRAM, cost disadvantage kills margins. But CXMT doesn't compete on cost—it competes on access. Chinese smartphone makers, server builders, and automakers are told to prioritize domestic suppliers. That captive demand provides a revenue floor.
Now overlay the geopolitical layer. CXMT is not on the BIS Entity List. Not yet. But its expansion plans—a second fab in Hefei, rumors of a Beijing facility—depend on ASML immersion DUV tools. Those tools require Dutch export licenses. After the October 2022 rules, ASML has effectively stopped delivering advanced systems to Chinese fabs. CXMT hoarded equipment before the crackdown, but maintenance and spare parts remain vulnerable. If the US upgrades CXMT to Entity List status, the fab could stop within months.
High-Flyer knows this. Their involvement is a hedge. By taking a strategic stake, they gain visibility into CXMT's roadmap and can influence decisions to prioritize HBM development. The 153 products act as a concentrated voting block. This is not about short-term IPO flipping. The lock-up periods for strategic placement shares are typically 12 months or more. High-Flyer is locking capital for a multi-year bet.
Let's quantify the valuation absurdity. Assuming CXMT generated 30 billion RMB in revenue in 2023 (estimate), a 2 trillion market cap gives a price-to-sales ratio of 66x. Samsung's PS ratio is 2x. SK Hynix's is 3x. Even accounting for growth, CXMT would need to capture 20% of the global DRAM market within five years to justify that multiple. Currently it holds 3%. Impossible? Not if policy mandates domestic sourcing. But even then, the capital expenditure required to scale from 10k wafers/month to 50k is enormous—hundreds of billions of RMB. The IPO only raises about 60 billion. They will need more equity or debt. Dilution is inevitable.
Liquidity vanishes. Code remains. The hardware is replaceable; the software stack is not. High-Flyer's true asset is its AI trading code. But that code needs memory to run. By investing in CXMT, they are essentially building a hardware supply chain for their own digital infrastructure. This is the ultimate vertical integration play in the age of AI.
Contrarian Angle
The market consensus reads this IPO as a bullish signal for China's tech decoupling. I disagree. The real story is the fragility of that decoupling. CXMT's technology is not indigenous—it relies on Japanese photoresist, American EDA tools, and Dutch lithography. The "made in China" label is a marketing convenience, not a technical reality.
Consider the HBM blind spot. AI training demand for HBM is growing at 30% CAGR. CXMT has zero exposure. If they cannot develop a competitive HBM product by 2027, they will miss the most profitable segment of the memory market. High-Flyer's investment might force a pivot, but pivoting in semiconductor manufacturing takes years. The clock is ticking.
Moreover, the 153-fund structure raises regulatory red flags. Is it a disguised form of insider participation? Are these products mostly owned by High-Flyer's own management? The CSRC (China Securities Regulatory Commission) will likely scrutinize this. If irregularities surface, the IPO could be delayed or canceled. That would be a liquidity event for the entire Chinese tech market.
Regulation doesn't fix physics. No amount of policy support can close the node gap overnight. CXMT will remain a follower, not a leader, for at least three to five years.
Takeaway
For macro observers, the CXMT IPO is a litmus test for China's semiconductor ambitions. If High-Flyer's bet pays off, it signals a successful alignment of capital, policy, and technology. If it fails, the fallout will ripple across Chinese AI and crypto mining supply chains. The key signal to watch: the US BIS entity list update in late 2024. If CXMT gets added, the liquidity that flowed into the IPO will vanish. The code—High-Flyer's AI models—will have to find memory elsewhere. That search will reshape global hardware markets.
Watch the wafers. Watch the capital flows. The rest is noise.